Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

China Precision Medical Device Market

ID: MRFR/MED/42168-HCR
200 Pages
Rahul Gotadki
Last Updated: April 06, 2026

China Precision Medical Device Market Research Report By Ecosystem Players Outlook (Pharmaceuticals and Biotechnology Companies Diagnostic Companies Healthcare IT Specialists/Big Data Companies Clinical Laboratories) By Sub-Markets Outlook (Companion Diagnostics Biomarker-Based Test Targeted Therapeutics Pharmacogenomics (PGX) Molecular Diagnostics) and By Therapeutics Outlook (Cancer/Oncology Cardiovascular Disease (CVD) Central Nervous System Infectious Diseases) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

China Precision Medical Device Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Application (USD Billion)
  49.     4.1.1 Diagnostic Imaging
  50.     4.1.2 Surgical Instruments
  51.     4.1.3 Monitoring Devices
  52.     4.1.4 Therapeutic Devices
  53.     4.1.5 Dental Equipment
  54.   4.2 Healthcare, BY End Use (USD Billion)
  55.     4.2.1 Hospitals
  56.     4.2.2 Clinics
  57.     4.2.3 Research Laboratories
  58.     4.2.4 Home Care
  59.     4.2.5 Ambulatory Surgical Centers
  60.   4.3 Healthcare, BY Product Type (USD Billion)
  61.     4.3.1 Electrophysiology Devices
  62.     4.3.2 Ultrasound Devices
  63.     4.3.3 Endoscopy Devices
  64.     4.3.4 Radiation Therapy Devices
  65.     4.3.5 Orthopedic Devices
  66.   4.4 Healthcare, BY Technology (USD Billion)
  67.     4.4.1 Robotic Surgery
  68.     4.4.2 3D Printing
  69.     4.4.3 Wearable Technology
  70.     4.4.4 Telemedicine Solutions
  71.     4.4.5 Nanotechnology
  72.   4.5 Healthcare, BY Material (USD Billion)
  73.     4.5.1 Metal
  74.     4.5.2 Plastic
  75.     4.5.3 Ceramic
  76.     4.5.4 Composite
  77.     4.5.5 Biomaterials
  78. 5 SECTION V: COMPETITIVE ANALYSIS
  79.   5.1 Competitive Landscape
  80.     5.1.1 Overview
  81.     5.1.2 Competitive Analysis
  82.     5.1.3 Market share Analysis
  83.     5.1.4 Major Growth Strategy in the Healthcare
  84.     5.1.5 Competitive Benchmarking
  85.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  86.     5.1.7 Key developments and growth strategies
  87.       5.1.7.1 New Product Launch/Service Deployment
  88.       5.1.7.2 Merger & Acquisitions
  89.       5.1.7.3 Joint Ventures
  90.     5.1.8 Major Players Financial Matrix
  91.       5.1.8.1 Sales and Operating Income
  92.       5.1.8.2 Major Players R&D Expenditure. 2023
  93.   5.2 Company Profiles
  94.     5.2.1 Medtronic (US)
  95.       5.2.1.1 Financial Overview
  96.       5.2.1.2 Products Offered
  97.       5.2.1.3 Key Developments
  98.       5.2.1.4 SWOT Analysis
  99.       5.2.1.5 Key Strategies
  100.     5.2.2 Siemens Healthineers (DE)
  101.       5.2.2.1 Financial Overview
  102.       5.2.2.2 Products Offered
  103.       5.2.2.3 Key Developments
  104.       5.2.2.4 SWOT Analysis
  105.       5.2.2.5 Key Strategies
  106.     5.2.3 Philips (NL)
  107.       5.2.3.1 Financial Overview
  108.       5.2.3.2 Products Offered
  109.       5.2.3.3 Key Developments
  110.       5.2.3.4 SWOT Analysis
  111.       5.2.3.5 Key Strategies
  112.     5.2.4 GE Healthcare (US)
  113.       5.2.4.1 Financial Overview
  114.       5.2.4.2 Products Offered
  115.       5.2.4.3 Key Developments
  116.       5.2.4.4 SWOT Analysis
  117.       5.2.4.5 Key Strategies
  118.     5.2.5 Johnson & Johnson (US)
  119.       5.2.5.1 Financial Overview
  120.       5.2.5.2 Products Offered
  121.       5.2.5.3 Key Developments
  122.       5.2.5.4 SWOT Analysis
  123.       5.2.5.5 Key Strategies
  124.     5.2.6 Stryker (US)
  125.       5.2.6.1 Financial Overview
  126.       5.2.6.2 Products Offered
  127.       5.2.6.3 Key Developments
  128.       5.2.6.4 SWOT Analysis
  129.       5.2.6.5 Key Strategies
  130.     5.2.7 B. Braun (DE)
  131.       5.2.7.1 Financial Overview
  132.       5.2.7.2 Products Offered
  133.       5.2.7.3 Key Developments
  134.       5.2.7.4 SWOT Analysis
  135.       5.2.7.5 Key Strategies
  136.     5.2.8 Fujifilm (JP)
  137.       5.2.8.1 Financial Overview
  138.       5.2.8.2 Products Offered
  139.       5.2.8.3 Key Developments
  140.       5.2.8.4 SWOT Analysis
  141.       5.2.8.5 Key Strategies
  142.     5.2.9 Mindray (CN)
  143.       5.2.9.1 Financial Overview
  144.       5.2.9.2 Products Offered
  145.       5.2.9.3 Key Developments
  146.       5.2.9.4 SWOT Analysis
  147.       5.2.9.5 Key Strategies
  148.     5.2.10 Shenzhen Huaqiang Medical (CN)
  149.       5.2.10.1 Financial Overview
  150.       5.2.10.2 Products Offered
  151.       5.2.10.3 Key Developments
  152.       5.2.10.4 SWOT Analysis
  153.       5.2.10.5 Key Strategies
  154.   5.3 Appendix
  155.     5.3.1 References
  156.     5.3.2 Related Reports
  157. 6 LIST OF FIGURES
  158.   6.1 MARKET SYNOPSIS
  159.   6.2 CHINA MARKET ANALYSIS BY APPLICATION
  160.   6.3 CHINA MARKET ANALYSIS BY END USE
  161.   6.4 CHINA MARKET ANALYSIS BY PRODUCT TYPE
  162.   6.5 CHINA MARKET ANALYSIS BY TECHNOLOGY
  163.   6.6 CHINA MARKET ANALYSIS BY MATERIAL
  164.   6.7 KEY BUYING CRITERIA OF HEALTHCARE
  165.   6.8 RESEARCH PROCESS OF MRFR
  166.   6.9 DRO ANALYSIS OF HEALTHCARE
  167.   6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  168.   6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  169.   6.12 SUPPLY / VALUE CHAIN: HEALTHCARE
  170.   6.13 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
  171.   6.14 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
  172.   6.15 HEALTHCARE, BY END USE, 2024 (% SHARE)
  173.   6.16 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Billion)
  174.   6.17 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE)
  175.   6.18 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Billion)
  176.   6.19 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
  177.   6.20 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Billion)
  178.   6.21 HEALTHCARE, BY MATERIAL, 2024 (% SHARE)
  179.   6.22 HEALTHCARE, BY MATERIAL, 2024 TO 2035 (USD Billion)
  180.   6.23 BENCHMARKING OF MAJOR COMPETITORS
  181. 7 LIST OF TABLES
  182.   7.1 LIST OF ASSUMPTIONS
  183.     7.1.1
  184.   7.2 China MARKET SIZE ESTIMATES; FORECAST
  185.     7.2.1 BY APPLICATION, 2026-2035 (USD Billion)
  186.     7.2.2 BY END USE, 2026-2035 (USD Billion)
  187.     7.2.3 BY PRODUCT TYPE, 2026-2035 (USD Billion)
  188.     7.2.4 BY TECHNOLOGY, 2026-2035 (USD Billion)
  189.     7.2.5 BY MATERIAL, 2026-2035 (USD Billion)
  190.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  191.     7.3.1
  192.   7.4 ACQUISITION/PARTNERSHIP
  193.     7.4.1

China Healthcare Market Segmentation

Healthcare By Application (USD Billion, 2026-2035)

  • Diagnostic Imaging
  • Surgical Instruments
  • Monitoring Devices
  • Therapeutic Devices
  • Dental Equipment

Healthcare By End Use (USD Billion, 2026-2035)

  • Hospitals
  • Clinics
  • Research Laboratories
  • Home Care
  • Ambulatory Surgical Centers

Healthcare By Product Type (USD Billion, 2026-2035)

  • Electrophysiology Devices
  • Ultrasound Devices
  • Endoscopy Devices
  • Radiation Therapy Devices
  • Orthopedic Devices

Healthcare By Technology (USD Billion, 2026-2035)

  • Robotic Surgery
  • 3D Printing
  • Wearable Technology
  • Telemedicine Solutions
  • Nanotechnology

Healthcare By Material (USD Billion, 2026-2035)

  • Metal
  • Plastic
  • Ceramic
  • Composite
  • Biomaterials

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions